In a recent development, VSee Health, Inc., a company operating within the health care sector, has made significant strides in its financial strategy by executing two convertible note agreements with institutional investors. This move, announced in a current report filed on July 7, 2026, underscores the company’s proactive approach to securing capital for its operations and future endeavors.
The first of these agreements, known as the ClearThink note, was issued on June 22, 2026. It carries a principal amount of $280,000 and includes a one-time interest charge of 10%. The second agreement, referred to as the Vanquish note, was issued slightly earlier, on June 18, 2026, with a principal of $295,550 and a one-time interest charge of 12%. Both notes are unsecured and are designed to convert into the company’s common stock after a period of 180 days. The conversion prices are strategically tied to the stock’s recent trading price, ensuring a fair valuation for both the company and the investors. Additionally, these notes are subject to a floor price and include a 4.99% ownership cap, which serves to protect the company’s existing shareholders from excessive dilution.
VSee Health, Inc. operates under the umbrella of Digital Health Acquisition Corp., a blank check company based in Boca Raton, United States. This parent company is listed on the Nasdaq stock exchange and is focused on acquiring businesses and assets through various means, including mergers, capital stock exchanges, and asset acquisitions. The strategic alignment between VSee Health, Inc. and Digital Health Acquisition Corp. positions the company well within the dynamic health care sector, leveraging opportunities for growth and expansion.
The convertible notes are exempt from registration under the Securities Act, a status that simplifies the process for both the company and its investors. Furthermore, VSee Health, Inc. has confirmed its compliance with all reporting obligations under the Securities Exchange Act, ensuring transparency and accountability in its financial dealings. The company has also reported no material adverse changes, reinforcing its stable position in the market.
The proceeds from these convertible notes are earmarked for general working-capital purposes. This allocation highlights the company’s focus on maintaining liquidity and supporting its operational needs as it navigates the competitive landscape of the health care sector. With a market capitalization of $5,346,000 and a recent close price of $0.106, VSee Health, Inc. is poised to leverage these financial instruments to bolster its strategic initiatives.
As the company continues to execute its plans, the health care sector will be watching closely. The successful deployment of the proceeds from the ClearThink and Vanquish notes could pave the way for significant advancements in VSee Health, Inc.’s offerings and market presence. This strategic financial maneuvering not only underscores the company’s commitment to growth but also its ability to attract and maintain strong relationships with institutional investors.
